Literature DB >> 28250863

Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT.

Gul Ege Aktas1, Nuray Can2, Selin Soyluoglu Demir1, Ali Sarıkaya1.   

Abstract

A 69-year-old male smoker was referred to 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) with the indication of a suspicious solitary pulmonary nodule. FDG PET/CT determined a 2.5 × 2-cm soft-tissue lesion (SUVmax, 16.2) with spiculated margins in the hilum of the right lung. A 1-cm diameter lymphadenopathy on the right hilum with an SUVmax of 3.2 was also determined. Transbronchial biopsy of the right hilar lymphadenopathy did not reveal any malignant features in histopathologic examination, and it was determined to be reactive. The patient underwent a right upper lobe segmentectomy, and the histopathologic evaluation revealed that the tumor was a primary lymphoepithelioma-like carcinoma (LELC) of the lung with negative Epstein-Barr virus (EBV) on in situ hybridization studies. In this case report, we mainly focus on the FDG avidity of this very rare kind of tumor comparatively with previous reports and possible explanations of discordancy in FDG avidity in relation to histopathologic characteristics.

Entities:  

Keywords:  FDG; Lung cancer; Lymphoepithelioma-like carcinoma; PET/CT; SUV

Year:  2016        PMID: 28250863      PMCID: PMC5313461          DOI: 10.1007/s13139-016-0428-7

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  19 in total

1.  [Lympnepithelial Schmincke-Regaud tumors].

Authors:  W DOERR
Journal:  Arztl Wochensch       Date:  1956-03-02

2.  Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.

Authors:  F F Chen; J J Yan; W W Lai; Y T Jin; I J Su
Journal:  Cancer       Date:  1998-06-15       Impact factor: 6.860

3.  Primary lymphoepithelioma-like carcinoma of the lung. A clinicopathologic study of 11 cases.

Authors:  J K Chan; P K Hui; W Y Tsang; C K Law; C C Ma; T T Yip; Y F Poon
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

Review 4.  The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas.

Authors:  J C Iezzoni; M J Gaffey; L M Weiss
Journal:  Am J Clin Pathol       Date:  1995-03       Impact factor: 2.493

Review 5.  Relationship between Epstein-Barr virus and lymphoepithelioma-like carcinoma of the lung: a clinicopathologic study of 6 cases and review of the literature.

Authors:  C Y Castro; M L Ostrowski; R Barrios; L K Green; H H Popper; S Powell; P T Cagle; J Y Ro
Journal:  Hum Pathol       Date:  2001-08       Impact factor: 3.466

6.  New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas.

Authors:  Yih-Leong Chang; Chen-Tu Wu; Jin-Yuan Shih; Yung-Chie Lee
Journal:  Am J Surg Pathol       Date:  2002-06       Impact factor: 6.394

Review 7.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

8.  18F-FDG PET/CT of Liver Lymphoepithelioma-like Carcinoma.

Authors:  Sin-Di Lee; Yu-Li Chiu; Chia-Shan Wu; Nan-Jing Peng
Journal:  Clin Nucl Med       Date:  2015-09       Impact factor: 7.794

Review 9.  Nonnasopharyngeal lymphoepitheliomas (undifferentiated carcinomas) of the upper aerodigestive tract.

Authors:  D K Frank; F Cheron; H Cho; D DiCostanzo; A P Sclafani
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-04       Impact factor: 1.547

10.  FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.

Authors:  Aisheng Dong; Jian Zhang; Yang Wang; Zhijun Zhai; Changjing Zuo
Journal:  Clin Nucl Med       Date:  2015-02       Impact factor: 7.794

View more
  1 in total

1.  Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma-like carcinoma.

Authors:  Chun-Yu Lin; Yu-Chuan Chang; I-Ting Wang; Meng-Heng Hsieh; Chih-Wei Wang; Shu-Min Lin; Ching-Yang Wu; Yueh-Fu Fang
Journal:  Oncol Lett       Date:  2019-10-02       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.